Observational Study
Copyright ©The Author(s) 2017.
World J Cardiol. Mar 26, 2017; 9(3): 268-276
Published online Mar 26, 2017. doi: 10.4330/wjc.v9.i3.268
Table 4 Acute event characteristics
PatientGenderAge (yr)ECGTroponin (μg/L)LVEF (%)DiagnosisLGE transmural extent1β-blocker useACEI useVTVFCMR delay (d)Ventricular arrhythmia length
13Male39STE0.351.7MI41010110 VPBs
52Male45Normal0.457.7MI30010110 VPBs
53Female30STE17.345.5MI41110030 VPBs
63Male51Normal0.357.8MI3111016 VPBs
64Male56STE1.661.2MI41110115 VPBs
75Male32STE0.863.2MI4101007 VPBs
92Male57STD0.448.1MI3101006 VPBs
128Female55STD0.649.8MI4111015 VPBs
97Male83STD0.246.5MI2111006 VPBs
3Male45STE0.166.9Myocarditis3101029 VPBs
37Male40STE4.856.1Myocarditis2011025 VPBs
44Male25STE36.665.7Myocarditis300013VF
94Male28STE1.457.1Myocarditis2101004 VPBs
76Male53STE1.469.6Myocarditis2111007 VPBs
104Female42STE21.257.1Myocarditis41010113 VPBs
131Female31STD0.651.7Myocarditis1101018 VPBs
80Male34STE0.453.1No LGE0011007 VPBs
125Male56Normal0.162.4No LGE0111043 VPBs